Company: MIRA
Filing Date: 2025-07-29
Form Type: PRER14A
Source: 0001641172-25-021434
Chunk: 229

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-07-29
Form: PRER14A
Chunk 229
---
 the Licensed Territory and solely in the Field of Use during the
Term of Agreement.

3.3 Right to Sublicense.
The licenses granted in Sections 3.1 and 3.2 include the right of Licensee to grant corresponding Sublicenses to third parties during
the Term of Agreement.

<div align='center'>ARTICLE 4—PATENT
MARKING</div>

4.1 Patent Marking. Licensee
agrees that all Licensed Products sold by Licensee, Affiliates, or Sublicensees will be legibly marked with the number of any applicable
patent(s) licensed hereunder as part of the Patent Rights in accordance with applicable law, including Title 35, U.S. Code, or if such
marking is not practicable, shall so mark the accompanying outer box or product insert for Licensed Products accordingly, or by virtual
marking to the extent permitted by law.

<div align='center'>ARTICLE 5—PATENT
ENFORCEMENT</div>

5.1 IP Enforcement. Licensee
shall have the primary right, but not the obligation, to take action in its own name to secure the cessation of any infringement or misappropriation
or to enter suit against the infringer in the Licensed Territory and in the Field of Use. Any such action will be at Licensee’s
expense, employing counsel of its own choosing. If Licensee elects not to exercise its right to prosecute or take other appropriate action
in connection with an infringement or misappropriation of the Patents Rights or fails to take any such action within sixty (60) days of
first receiving notice of such infringement or misappropriation, Licensor may do so at its own expense, controlling such action. In the
event of any infringement or misappropriation suit against a third party brought by either Party pursuant to this Section, the Party so
proceeding shall pay to the other Party all of its costs and expenses (but not attorney’s fees) in connection with such action and
such other Party shall join in and reasonably cooperate with respect to such action to the extent necessary to initiate and maintain it
(e.g., by providing relevant documents, witnesses and testimony, etc.).

<div align='center'>ARTICLE 6—PATENT
PROSECUTION</div>

6.1 IP Procurement. Licensor
will have sole control over the filing, prosecution, maintenance, and management of any and all issued patents and pending and future
patent applications encompass